WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark was filed as Figurative mark on 08/07/2019 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Armillary spheres, planetaria, astronomic orbits, atomic models, molecular models #Parts of the human body, skeletons, skulls #Atomic models, molecular models, representations of human, animal or vegetal cells #Other parts of the human body, DNA band, cells, brains, sperms, hair roots (also 2.9.12)

Trademark Details Last update: July 21, 2023

Trademark form Figurative mark
File reference 1500244
Countries Australia Bosnia and Herzegovina Bahrain Canada Switzerland Czechia Algeria Egypt United Kingdom India South Korea Mexico Norway New Zealand Oman Slovenia Slovakia Thailand Turkey Ukraine
Base trademark US No. 88514434, July 15, 2019
Application date August 7, 2019
Expiration date August 7, 2029

Trademark owner

215 First Street
Cambridge MA 02142
US

Trademark representatives

250 West 55th Street New York NY 10019-9710 US

goods and services

05 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform; pharmaceutical preparations that modulate rna expression; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products for the treatment of genetic disorders and diseases

Trademark history

Date Document number Area Entry
August 18, 2021 2021/35 Gaz US RAW: Partial Ceasing Effect
June 28, 2021 2021/26 Gaz MX Rejection
April 23, 2021 2021/18 Gaz TH Rejection
March 8, 2021 2021/11 Gaz CA Rejection
February 1, 2021 2021/5 Gaz KR Rejection
December 23, 2020 2020/52 Gaz TR Rejection
December 4, 2020 2020/50 Gaz BA Rejection
November 16, 2020 2020/47 Gaz UA Rejection
October 26, 2020 2020/44 Gaz CH Rejection
October 22, 2020 2020/43 Gaz DZ Rejection
October 15, 2020 2020/42 Gaz NO Rejection
September 29, 2020 2020/40 Gaz IN Rejection
June 22, 2020 2020/26 Gaz SI Rejection
May 20, 2020 2020/21 Gaz AU Rejection
May 6, 2020 2020/20 Gaz SK Rejection
April 27, 2020 2020/18 Gaz CZ Rejection
March 25, 2020 2020/13 Gaz NZ Rejection
February 13, 2020 2020/7 Gaz GB Rejection
August 7, 2019 2019/46 Gaz US Registration

ID: 141500244